Judit Rius,Attorney and Foreign Law Advisor, Knowledge Ecology International With commentary by JESSICA LITMAN, John F. Nickoll Professor of Law Abstract: The current system to finance drug development based on strong intellectual property rights is failing many in both developing and developed countries. The system promotes monopolies that make products unaffordable, and fails to provide incentives for urgently needed diagnostics and treatments for neglected diseases.
